Company profile for Neukio Biotherapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Neukio (Shanghai) Biotherapeutics was founded June 2021 in Shanghai FTZ, Neukio pioneers iPSC-derived, off-the-shelf immune cell therapies for solid tumors and autoimmune diseases. Dual innovation in product/process development expands indications while slashing production costs for accessible, high-quality global treatments. Features 6,000m² integrated R&D/GMP facility (1,000m² lab + 2,500m² cleanrooms) enabling end-to-end...
Neukio (Shanghai) Biotherapeutics was founded June 2021 in Shanghai FTZ, Neukio pioneers iPSC-derived, off-the-shelf immune cell therapies for solid tumors and autoimmune diseases. Dual innovation in product/process development expands indications while slashing production costs for accessible, high-quality global treatments. Features 6,000m² integrated R&D/GMP facility (1,000m² lab + 2,500m² cleanrooms) enabling end-to-end operations from discovery to manufacturing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
3F, Building 7-5, No. 160 Basheng Road, China (Shanghai) Pilot Free Trade Zone...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty